Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential AG and ITP Chemotherapy in Advanced Urothelial Carcinoma
NCT00003105Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 1997
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in urothelial carcinoma (UC), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 1997; status: completed.
02
Drugs
gemcitabine
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00003105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003105.